HDAC inhibitors target crucial oncogene and tumor immune microenvironment in TNBC
Dr. Rumela Chakrabarti's team found that the protein ΔNp63 helps triple-negative breast cancer suppress immunity in mice, and the HDAC inhibitor Quisinostat lowered it, slowing tumour growth and spread.